On the diagnostic test accuracy of N-terminal pro-brain natriuretic peptide (NT-proBNP) for pulmonary arterial hypertension in patients with systemic sclerosis. Comment on: "Diagnostic value of cardiac natriuretic peptide on pulmonary hypertension in systemic sclerosis: a systematic review and meta-analysis" by Zhang et al. Joint Bone Spine 2021:105287

Joint Bone Spine. 2022 May;89(3):105317. doi: 10.1016/j.jbspin.2021.105317. Epub 2021 Dec 4.

¹ Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University General Hospital, University of Thessaly, Viopolis, Larissa, Greece.
² Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University General Hospital, University of Thessaly, Viopolis, Larissa, Greece; Department of Nutritional Sciences and Dietetics, Faculty of Health Sciences, International Hellenic University, Alexander Campus, Thessaloniki, Greece.
³ Department of Rheumatology and Clinical Immunology, Faculty of Medicine, School of Health Sciences, University General Hospital, University of Thessaly, Viopolis, Larissa, Greece. Electronic address: bogdanos@med.uth.gr.

No abstract available

Keywords: Biomarker; Prognosis; Pulmonary arterial hypertension; Systemic sclerosis; Treament.

Publication types